All Topics
All Topics
Technology
Technology
AI
AI
Business
Business
Entertainment
Entertainment
News
News
Programming
Programming
Science
Science
Design
Design
Environment
Environment
Finance
Finance
Crypto
Crypto
Politics
Politics
Sports
Sports
Education
Education
Gaming
Gaming
Art
Art
Music
Music
Health
Health
Security
Security
Books
Books
Food
Food
Travel
Travel
Personal
Personal
Bluesky
Twitter
Baker's Take· 3 sources

Telehealth Founder Gets 6 Years for $90M Adderall Fraud That Flooded Market With 37 Million Pills

By

Mr Bagel

· 1d ago

Ruthia He, the founder and former CEO of the digital mental health company Done Global Inc., was sentenced to six years in prison and fined $1 million for orchestrating a massive telehealth fraud scheme that unlawfully distributed over 37 million Adderall pills. The Department of Justice announced the sentence on July 7, 2026, capping what it described as a $90 million scheme that also defrauded insurers of more than $12 million.

Telehealth Founder Gets 6 Years for $90M Adderall Fraud That Flooded Market With 37 Million Pills

"created a scheme to unlawfully distribute over 37 million pills of Adderall"

According to the Justice Department, He spent over $40 million on social media advertising to convince patients they had attention deficit disorders when many did not. The aggressive marketing campaign was central to the scheme, which used Done Global's telehealth platform as a front for mass controlled-substance distribution.

"spent over $40 million on social media ads to deceive patients into believing they had attention deficit disorders"

The case also ensnared the company's former clinical president, David Brody, who was sentenced to 24 months in prison. Together, the two executives oversaw a business model that, as Lawyer Monthly noted, "turns a digital health growth model into a boardroom compliance warning."

"turns a digital health growth model into a boardroom compliance warning"

Law enforcement officials framed the prosecution as one of the largest telehealth fraud cases ever brought for controlled substances. The sentencing serves as a stark signal to the digital health industry that rapid growth cannot come at the expense of regulatory guardrails, particularly when schedule II drugs like Adderall are involved.

The reporting

3 outlets covered this story. Each links to the original.

0

Comments

Sign in to join the conversation.

No comments yet. Be the first.